Efficacy of 100 mg of double-bolus alteplase in achieving complete perfusion in the treatment of acute myocardial infarction.

[1]  D. Mccluskey,et al.  Anaphylactoid reaction after injection of alteplase , 1993, The Lancet.

[2]  R. Laing,et al.  Postgraduate district hospital training in Zambia , 1993, The Lancet.

[3]  G. A. Murphy,et al.  Randomized angiographic trial of recombinant tissue-type plasminogen activator (alteplase) in myocardial infarction. RAAMI Study Investigators. , 1992, Journal of the American College of Cardiology.

[4]  D. Lipkin,et al.  Effectiveness and safety of a single intravenous Bolus injection of tissue-type plasminogen activator in acute myocardial infarction , 1992 .

[5]  C. Wilson,et al.  Effectiveness of double bolus alteplase in the treatment of acute myocardial infarction. , 1991, The American journal of cardiology.

[6]  D. Massel,et al.  Anaphylactoid reaction during an infusion of recombinant tissue-type plasminogen activator for acute myocardial infarction. , 1991, The Canadian journal of cardiology.

[7]  F. Dunn,et al.  A pilot study of the efficacy and safety of bolus administration of alteplase in acute myocardial infarction. , 1991, British heart journal.

[8]  J. Hirsh,et al.  A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. , 1990, Chest.

[9]  A. Maseri,et al.  Effectiveness of multiple bolus administration of tissue-type plasminogen activator in acute myocardial infarction. , 1990, The American journal of cardiology.

[10]  G. Agnelli.  Rationale for bolus t-PA therapy to improve efficacy and safety. , 1990, Chest.

[11]  E. Braunwald.  Enhancing thrombolytic efficacy by means of "front-loaded" administration of tissue plasminogen activator. , 1989, Journal of the American College of Cardiology.

[12]  U. Tebbe,et al.  Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator. , 1989, Journal of the American College of Cardiology.

[13]  E. Seifried,et al.  Single-bolus injection of recombinant tissue-type plasminogen activator in acute myocardial infarction. , 1989, The American journal of cardiology.

[14]  A. M. Skene,et al.  TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION Anglo-Scandinavian Study of Early Thrombolysis (ASSET) , 1988, The Lancet.

[15]  I. Palacios,et al.  Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion. , 1986, Circulation.

[16]  J. Hirsh,et al.  The thrombolytic and hemorrhagic effects of tissue type plasminogen activator: influence of dosage regimens in rabbits. , 1985, Thrombosis research.

[17]  W. Ganz,et al.  The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.

[18]  Barr Jb,et al.  HOME OR AWAY? , 1964, Lancet.

[19]  J. Anderson,et al.  Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study. Second Multicenter Thrombolysis Trial of Eminase in Acute Myocardial Infarction. , 1992, Journal of the American College of Cardiology.

[20]  C. Kawai.  Multicenter trial of a novel modified t-PA, E6010, by i.v.bolus injection in patients with acute myocardial infarction. , 1992 .

[21]  F. Pileggi,et al.  Intravenous bolus administration of recombinant tissue plasminogen activator to patients with acute myocardial infarction , 1990 .

[22]  P. Holvoet,et al.  Time course of thrombolysis induced by intravenous bolus or infusion of tissue plasminogen activator in a rabbit jugular vein thrombosis model. , 1989, Circulation.

[23]  H. S. Mueller,et al.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.